These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 198545)

  • 1. Prostaglandin isosteres. 1. (8-Aza-, 8,10-diaza-, and 8-aza-11-thia)-9-oxoprostanoic acids and their derivatives.
    Smith RL; Lee T; Gould NP; Cragoe EJ
    J Med Chem; 1977 Oct; 20(10):1292-9. PubMed ID: 198545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11,12-Secoprostaglandins. 2. N-acyl-N-alkyl-7-aminoheptanoic acids.
    Jones JH; Holtz WJ; Bicking JB; Cragoe EJ; Mandel LR; Kuehl FA
    J Med Chem; 1977 Jan; 20(1):44-8. PubMed ID: 189029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11,12-Secoprostaglandins. 3. 8-Alkylthio(sulfinyl and sulfonyl)-12-hydroxyalkanoic acids and related compounds.
    Smith RL; Bicking JB; Gould NP; Lee T; Robb CM; Kuehl FA; Mandel LR; Cragoe EJ
    J Med Chem; 1977 Apr; 20(4):540-7. PubMed ID: 191613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11,12-secoprostaglandins. 4. 7-(N-alkylmethanesulfonamido) heptanoic acids.
    Jones JH; Holtz WJ; Bicking JB; Cragoe EJ
    J Med Chem; 1977 Oct; 20(10):1299-304. PubMed ID: 198546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11,12-Secoprostaglandins. 1. Acylhydroxyalkanoic acids and related compounds.
    Bicking JB; Robb CM; Smith RL; Cragoe EJ
    J Med Chem; 1977 Jan; 20(1):35-43. PubMed ID: 189028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced platelet aggregation.
    Venton DL; Enke SE; Le Breton GC
    J Med Chem; 1979 Jul; 22(7):824-30. PubMed ID: 109614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and platelet aggregation inhibitory activity of 10-oxa and 10-thia prostanoic acid derivatives.
    Das J; Vu T
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():788-93. PubMed ID: 2960192
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of some derivatives of 19,20-di-norprostanoic acid.
    Valcavi U; Innocenti S; Zabban GB; Pezzini C
    Farmaco Sci; 1975 Jul; 30(7):527-35. PubMed ID: 1149880
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific 3H-PGE1 binding sites in rat ovary in estrous cycle and pregnancy.
    Seböková E; Kolena J
    Physiol Bohemoslov; 1979; 28(1):25-30. PubMed ID: 220649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cyclic AMP from the superfused prepubertal rat ovary stimulated with human chorionic gonadotrophin (HCG) and prostaglandin E1 (PGE1).
    Liljekvist J; Grönquist L; Johansson SA
    Life Sci; 1976 Sep; 19(6):893-901. PubMed ID: 184360
    [No Abstract]   [Full Text] [Related]  

  • 12. 11,12-Secoprostaglandins. 5. 8-Acetyl- or 8-(1-hydroxyethyl)-12-hydroxy-13-aryloxytridecanoic acids and sulfonamide isosteres as inhibitors of platelet aggregation.
    Bicking JB; Jones JH; Holtz WJ; Robb CH; Kuehl FA; Minsker DH; Cragoe EJ
    J Med Chem; 1978 Oct; 21(10):1011-8. PubMed ID: 214552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins and congeners. 11. Synthesis of dl-13-hydroxyprostanoic acids.
    Wissner A
    J Org Chem; 1977 Jan; 42(2):356-8. PubMed ID: 830868
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S; Whittle BJ
    Br J Pharmacol; 1986 Aug; 88(4):931-6. PubMed ID: 3017497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 7-aza- and 13-aza-prostanoids on platelet aggregation].
    Kuz'mitskiĭ BB; Malaeva LP; Khlevnikova TS; Lakhvich FA
    Farmakol Toksikol; 1989; 52(4):45-8. PubMed ID: 2806527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of (+/-) 8,12-trans-delta5-en-cis-9-keto-13,14-en-trans-15-R,S-hydroxyprostanoic acid methyl ester.
    Traverso G; Pirillo D; Damonti E; Rescia G
    Farmaco Sci; 1978 Jul; 33(7):562-4. PubMed ID: 744254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of (+)-prostanoic acid (1).
    Sakai K; Inouye K; Nakamura N
    Prostaglandins; 1976 Sep; 12(3):399-401. PubMed ID: 968053
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions of a phosphodiesterase inhibitor, 3-isobutyl-1-methyl xanthine, with prostaglandin E2, follicle-stimulating hormone, luteinizing hormone, and dibutyryl cyclic 3',5'-adenosine monophosphate (cAMP) in cAMP and steroid production by neonatal rat ovaries in vitro.
    Reddoch RB; Armstrong DT
    Endocrinology; 1984 Jul; 115(1):11-8. PubMed ID: 6203725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for a prostaglandin receptor and its application to prostaglandin measurements (rat-adipocytes-antagonists-analogues-mouse ovary assay).
    Kuehl FA; Humes JL
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):480-4. PubMed ID: 4333988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor.
    Wright DH; Nantel F; Metters KM; Ford-Hutchinson AW
    Eur J Pharmacol; 1999 Jul; 377(1):101-15. PubMed ID: 10448933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.